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Introduction
Mifepristone and misoprostol offer an alternative to an
operative abortion for some women with unwanted
early pregnancies. For women with a large myomatous
uterus that would make an operation potentially
dangerous or technically difficult, a medically induced
abortion may be the only way to terminate an early
pregnancy. This case report details the administration
of mifepristone and misoprostol to abort an early
pregnancy in a woman with a markedly enlarged
leiomyomatous uterus.
Case Report
A 34-year-old, gravida 1, para 0, woman with an un-
wanted pregnancy of 6 weeks’ gestation was referred
to our hospital because of a large myomatous uterus,
which was anticipated to make an early operative
abortion difficult. The patient had a 6-year history
of leiomyomas with irregular menstruation and
menorrhagia. At admission, transabdominal ultra-
sonography revealed a large uterus (24 = 18 = 12 cm)
with multiple myomas, an irregular uterine cavity, and
a fundally located 10 mm intrauterine gestational sac,
corresponding to 42 days of gestation. There was no
embryonic cardiac activity. The gestational sac could
not be visualized by transvaginal ultrasonography; a
transducer had to be placed in the patient’s umbilicus
in order to locate the gestational sac. The distance
between the external cervical os and the level of the
gestational sac was estimated to be more than 22 cm.
There were nine measurable myomas present, the largest
of which measured 10 = 10 = 9 cm and was located in
the posterior lower uterine segment. Because of the
fundal location of the pregnancy, it was thought that an
operative abortion at this early gestational stage would
be difficult and potentially technically impossible.
The patient’s baseline hemoglobin level was 10.8
mg/dL. Subsequently, she was administered three tablets
of mifepristone 200 mg, followed by three tablets of
misoprostol 200 +g 48 hours later. However, there was
a lack of response to this regimen. Ultrasonography dem-
onstrated the continued presence of an intrauterine
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gestational sac 2 days after misoprostol administra-
tion. Five tablets of misoprostol 200 +g were therefore
placed into the posterior fornix of the vagina. The pa-
tient was simultaneously given two tablets of aceta-
minophen 500 mg for pain control. Vaginal bleeding
occurred 4 hours later.
The patient returned 2 days later for evaluation. At
that time, ultrasonography revealed no intrauterine
gestational sac and no change in the size of the myomas.
The bleeding lasted for 8 days. Total blood loss was
estimated to be 100 mL. Only mild pelvic pain was
reported by the patient. The urinary pregnancy test was
interpreted as being negative 3 weeks later.
Discussion
This case demonstrates the use of a medical option to
terminate a pregnancy in a patient who would otherwise
have faced a potentially difficult or impossible operation.
The enlarged and irregular cavity and the fundal position
of the gestational sac made the pregnancy potentially
inaccessible to a suction cannula.
A prior publication detailed the use of methotrexate
for an abortion in a patient at 8–9 weeks’ gestation with
a myomatous uterus that was enlarged to the size of 32–
34 weeks’ gestation [1]. However, it is currently common
to use mifepristone and misoprostol as an abortifacient
in early pregnancies.
Misoprostol is designed for oral use, for the pre-
vention and treatment of gastric ulcers. A combina-
tion of mifepristone followed 2 days later by the
prostaglandin analog, misoprostol, has proven to
be an effective method for termination of an early
pregnancy. This regimen leads to complete medical
abortion in approximately 95% of women [2,3]. How-
ever, our patient was unresponsive to this regimen. We
then switched to vaginal misoprostol, which has been
shown to be more effective than oral misoprostol for
this purpose. A pharmacokinetic study showed that the
systemic bioavailability of vaginally administered
misoprostol is 3 times higher than that of orally
administered misoprostol [4].
The administration of misoprostol is associated
with side effects due to its effect on smooth muscles;
these include low abdominal pain, diarrhea, nausea
and vomiting, and even cardiovascular collapse [5].
Therefore, the use of misoprostol is contraindicated in
patients with cardiac disease. The frequency of side
effects is related to the dose of misoprostol as well as its
route of administration. Oral misoprostol is associated
with a relatively high incidence of nausea and vomiting
when compared with the same dose administered
vaginally [3]. Only mild pelvic pain was reported by our
patient after vaginal administration of misoprostol
1,000 +g. We gave her acetaminophen as an analgesic;
it did not seem to interfere with the action of miso-
prostol in inducing uterine contractions and pregnancy
expulsion [6].
There are few reports regarding medical abortions
with a large myomatous uterus. Creinin [7] detailed the
successful use of methotrexate and misoprostol in a
patient at 5 weeks of gestation with a large myomatous
uterus. In addition, Carbonell et al [8] reported a 93%
success rate with vaginal misoprostol 1,000 +g for
women with gestations between 42 and 63 days. In our
patient, complete abortion was also achieved with
vaginal misoprostol 1,000 +g. Therefore, supplementary
use of a high dose of vaginal misoprostol may be
considered as an alternative for terminating an early
pregnancy associated with a myomatous uterus when
the conventional combination of mifepristone and
misoprostol fails.
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